Acne affects millions worldwide, often persisting well beyond adolescence into adulthood. Despite topical creams and treatments, stubborn breakouts remain a challenge for many. Now, researchers at the University of California, San Diego, are pioneering a potential solution: a vaccine against acne.
Lead researcher Eric C. Huang explained to Allure.com, "Acne is partly caused by the bacterium P. acnes, which we all carry throughout our lives. While beneficial in some ways, it secretes a protein that triggers inflammation and acne. We've identified an antibody that neutralizes this protein." In the U.S., nearly 50 million people grapple with acne, from mild pimples to severe cases. In France, Dermato info estimates 15 million affected, including 20% of adult women—a figure rising yearly, according to dermatologist Joshua Zeichner.
The vaccine now advances to clinical trials on patients, a process expected to take at least two years before potential approval. These developments offer real hope for effective, long-term acne relief.
